Maternal pathophysiology in pre-eclampsia

Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 13, Issue 1, 1999, Pages 59-75

  Kenny, Louise ^a   Baker, Philip N ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cerebral system; Coagulation; Eclampsia; Haemodynamics; Liver; Pathophysiology; Pre eclampsia; Renal system

Indexed keywords

REGULATOR PROTEIN;

BLOOD CLOTTING DISORDER; BLOOD VOLUME; BRAIN DISEASE; CARDIOVASCULAR DISEASE; FEMALE; FIBRINOLYSIS; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; LIVER DISEASE; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

BLOOD COAGULATION; BLOOD PLATELETS; BLOOD VOLUME; BRAIN; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY DISEASES; LIVER DISEASES; PRE-ECLAMPSIA; PREGNANCY; SEIZURES;

EID: 0032710974     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.1999.0006     Document Type: Article

References (86)

1. Ahmed Y, Sullivan MH & Elder MG (1991) Detection of platelet desensitization in pregnancy-induced hypertension is dependent on the agonist used. Thrombosis and Haemostasis 65: 474-477.
2. Anzar J, Gilibert J, Estelles A & Espana F (1986) Fibrinolytic activity and protein C in pre-eclampsia. Thrombosis and Haemostasis 55: 314-317.
3. Arias F & Mancilla-Jimenez R (1976) Hepatic fibrinogen deposits in pre-eclampsia. New England Journal of Medicine 295: 578-582.
4. Ashworth JR, Warren AY, Baker PN & Johnson IR (1997) Loss of endothelium dependent relaxation in myometrial resistance arteries in pre-eclampsia. British Journal of Obstetrics and Gynaecology 104: 1152-1159.
5. *Ashworth JR, Warren AY, Johnson IR & Baker PN (1998) Plasma from pre-eclamptic women and functional change in myometrial resistance arteries. British Journal of Obstetrics and Gynaecology 105: 459-461.
6. Audibert F, Friedman SA, Frangieh AY & Sibai BM (1996) Clinical utility of strict diagnostic criteria for the HELLP syndrome. American Journal of Obstetrics and Gynecology 175: 460-464.
7. Baker PN, Broughton Pipkin F & Symonds EM (1991) Platelet angiotensin II binding sites in normotensive and hypertensive women. British Journal of Obstetrics and Gynaecology 98: 436-440.
8. Baker PN, Broughton Pipkin F & Symonds EM (1992) Comparative study of platelet angiotensin II binding and the angiotensin li sensitivity test as predictors of pregnancy-induced hypertension. Clinical Science 83: 89-95.
9. Ballegeer VC, Spitz B, De Baene LA et al (1992) Platelet activation and vascular damage in gestational hypertension. American Journal of Obstetrics and Gynecology 166: 629-633.
10. Benedetti TJ, Cotton DB, Read JC & Miller FC (1980) Haemodynamic observations in severe pre-eclampsia with a flow-directed pulmonary artery catheter. American Journal of Obstetrics and Gynecology 136: 465-470.
11. Bond AL, August P, Druzin M et al (1989) Atrial natrieretic factor in normal and hypertensive pregnancy. American Journal of Obstetrics and Gynecology 160: 1112-1116.
12. Borok Z, Weitz J, Owen J et al (1984) Fibrinogen proteolysis and platelet alpha-granule release in pre-eclampsia/eclampsia. Blood 63: 525-531.
13. Brant JT (1985) Current concepts of coagulation. Clinical Obstetrics and Gynaecology 28: 3-14.
14. Brenner B, Lanir N & Thaler I (1996) HELLP syndrome associated with factor V R506 Q mutation. British Journal of Haematology 92: 999-1001.
15. Brown MA, Zammit VC & Mitar DM (1992) Extracellular fluid volumes in pregnancy-induced hypertension. Journal of Hypertension 10: 61-68.
16. Burrows RF, Hunter DJ, Andrew M & Kelton JG (1987) A prospective study investigating the mechanism of thrombocytopenia in pre-eclampsia. Obstetrics and Gynecology 70: 334-338.
17. Butler NR & Bonham DG (1963) In Perinatal Mortality, pp 86-100. Edinburgh: E&S Livingstone.
18. Carter J (1990) Liver function in normal pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 30: 296-302.
19. Chesley LC (1972) Plasma and red cell volumes during pregnancy. American Journal of Obstetrics and Gynecology 112: 440-450.
20. Chesley LC (1978) In Hypertensive Disorders of Pregnancy, pp 157-162. New York: Century-Appleton-Crofts.
21. Comp PC, Jacocks RM, Ferrell GL & Esmon CT (1982) Activation of protein C in vivo. Journal of Clinical Investigation 70: 127-134.
22. Cunningham FG, Fernandez CO & Hernandez C (1995) Blindness associated with pre-eclampsia and eclampsia. American Journal of Obstetrics and Gynecology 172: 1291-1298.
23. Dani R, Mendes GS, Medeiros J de L et al (1996) Study of the liver changes occurring in pre-eclampsia and their possible pathogenetic connection with acute fatty liver of pregnancy. American Journal of Gastroenterology 91: 292-294.
24. De Boer K, Buller HR, Ten Cate JW & Treffers PE (1991) Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. British Journal of Obstetrics and Gynaecology 98: 42-47.
25. Dekker GA, deVries JI, Doelitzsch PM et al (1995) Underlying disorders associated with severe early-onset pre-eclampsia. American Journal of Obstetrics and Gynecology 173: 1042-1048.
26. Douglas JT, Shah M, Lowe GD et al (1982) Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thrombosis and Haemostasis 47: 54-55.
27. Douglas KA & Redman CW (1994) Eclampsia in the United Kingdom. British Journal of Obstetrics and Gynaecology 309: 1395-1400.
28. Easterling TR & Benedetti TJ (1989) Pre-eclampsia: a hyperdynamic disease model. American Journal of Obstetrics and Gynecology 160: 1447-1453.
29. EasterlingTR, Benedetti TJ, Schmucker BC & Millard SP (1990) Maternal haemodynamics in normal and pre-eclamptic pregnancy: a longitudinal study. Obstetrics and Gynecology 76: 1061-1069.
30. Fenton V, Saunders K & Cavill I (1977) The platelet count in pregnancy. Journal of Clinical Pathology 30: 68-69.
31. Fernandez JA, Estelles A & Gilabert J (1989) Functional and immunological protein S in normal pregnant women and in full term neonates. Thrombosis and Haemostasis 61: 474-478.
32. Fisher KA, Luger A, Spargo BH & Linheimer MD (1981) Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine 60: 267-276.
33. Fitzgerald DJ, Rocki W, Murray R et al (1990) Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 335: 751-754.
34. Gant NF, Madden JD, Siiteri PK & MacDonald PC (1972) Fetal-placental maternal inter-relationships: a sequential study of the metabolism of dehydroepiandrosterone sulphate in primigravid pregnancy. In Endocrinology: International Congress Series, vol. 273, p 1026.
35. Gant NF, Daley GL, Chand S et al (1973) A study of angiotensin II pressor response throughout primigravid pregnancy. Journal of Clinical Investigation 52: 2682-2689.
36. Giles C & Inglis TC (1981) Thrombocytopenia and macrothrombocytosis in gestational hypertension. British Journal of Obstetrics and Gynaecology 88: 1115-1119.
37. Girling JC, Dow E & Smith JH (1997) Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. British Journal of Obstetrics and Gynaecology 104: 246-250.
38. Gonzalez R, Alberca I & Vincente V (1985) Protein C levels in late pregnancy, post partum and in women on oral contraceptives. Thrombosis Research 39: 637-641.
39. Goodlin RC (1990) HELLP does not always mean immediate HELP! American Journal of Obstetrics and Gynecology 163: 1089.
40. Govan ADT (1961) The pathogenesis of eclamptic lesions. Pathology and Microbiology 24: 561.
41. Groenendijk R, Trimbos JB & Wallenburg HC (1984) Haemodynamic measurements in pre-eclampsia: preliminary observations. American Journal of Obstetrics and Gynecology 150: 232-236.
42. Hamilton HFH (1950) The transactions of the Edinburgh Obstetrical Society: symposium on haemodynamics in pregnancy; cardiac output in pregnancy. Edinburgh Medical Journal 57: 1.
43. Hays PM, Cruickshank DP & Dunn L (1985) Plasma volume determination in normal and pre-eclamptic pregnancies. American Journal of Obstetrics and Gynecology 151: 958-966.
44. Henny CP, Lim AE, Brummelkamp WH et al (1983) A review of the importance of the multidisciplinary treatment following spontaneous rupture of the liver capsule during pregnancy. Surgery, Gynecology and Obstetrics 156: 593-598.
45. Higby K, Suiter CR, Phelps JY et al (1994) Normal values of urinary albumin and total protein excretion during pregnancy. American Journal of Obstetrics and Gynecology 171: 984-989.
46. Hirai N, Yanaihara T, Nakayama T et al (1988) Plasma levels of atrial natriuretic peptide during normal pregnancy and in pregnancy complicated by hypertension. American Journal of Obstetrics and Gynecology 159: 27-31.
47. Kincaid-Smith P (1991) The renal lesion of pre-eclampsia revisited. American Journal of Kidney Disease 17: 144-148.
48. Leduc L, Wheeler JM, Kirshon B et al (1992) Coagulation profile in severe pre-eclampsia. Obstetrics and Gynecology 79: 14-18.
49. Maki M (1983) Coagulation, fibrinolysis, platelet and kinin-forming systems during toxaemia of pregnancy. Biological Research in Pregnancy and Perinatology 4: 152-154.
50. *McCarthy AL, Woolfson RG, Raju SK & Poston L (1993) Abnormal endothelial cell function of resistance arteries from women with pre-eclampsia. American Journal of Obstetrics and Gynecology 168: 1323-1330.
51. Moller B & Lindmark G (1986) Eclampsia in Sweden, 1976-1980. Acta Obstetricia et Gynecologica Scandinavica 65: 307-314.
52. Moore MP & Redman CW (1983) Case control study of severe pre-eclampsia of early onset. British Medical Journal 287: 580-583.
53. Morriss MC, Twickler DM, Hatab MR et al (1997) Cerebral blood flow and cranial magnetic imaging in eclampsia and severe pre-eclampsia. Obstetrics and Gynecology 89: 561-568.
54. Naidu K, Moodley J, Corr P & Hoffman M (1997) Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. British Journal of Obstetrics and Gynaecology 104: 1165-1172.
55. Oosterhof H, Voorhoeve PG & Aarnoudse JG (1994) Enhancement of hepatic artery resistance to blood flow in pre-eclampsia in presence or absence of HELLP syndrome. American Journal of Obstetrics and Gynecology 171: 526-530.
56. Paternoster D, Stella A, Simioni P et al (1994) Clotting inhibitors and fibrinonectin as potential markers in pre-eclampsia. International Journal of Gynaecology and Obstetrics 47: 215-221.
57. Qureshi Al, Frankel MR, Ottenlips JR & Stern BJ (1996) Cerebral haemodynamics in pre-eclampsia. Archives of Neurology 53: 1226-1231.
58. Rakoczi I, Tallian F, Bagdany S & Gati I (1979) Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope technique. Thrombosis Research 15: 553-556.
59. Redman CW, Beilin LJ & Bonnar J (1976) Renal function in pre-eclampsia. Journal of Clinical Pathology 29 (supplement 10): 91-94.
60. Redman CW, Bonnar J & Beilin L (1978) Early platelet consumption in pre-eclampsia. British Medical Journal 1: 467-469.
61. Redman CW, Allington MJ, Bolton FG & Stirrat GM (1977a) Plasma beta-thromboglobulin in pre-eclampsia. Lancet 2: 248.
62. Redman CW, Denson KW, Beilin LJ et al (1977b) Factor VIII consumption in pre-eclampsia. Lancet 2: 1249-1252.
63. *Roberts JM & Redman CW (1993) Pre-eclampsia: more than pregnancy induced hypertension. Lancet 34: 1447-1451.
64. *Rodgers GM, Taylor RN & Roberts JM (1988) Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells. American Journal of Obstetrics and Gynecology 158: 908-914.
65. Rolfes DB & Ishak KG (1986) Liver disease in pregnancy. Histopathology 10: 555-570.
66. Romero R, Vizoso J, Emamian M et al (1988) Clinical significance of liver dysfunction in pregnancy-induced hypertension. American Journal of Perinatology 5: 146-151.
67. Schiff E, Friedman SA, Kao L & Sibai BM (1996) The importance of urinary protein excretion in the conservative management of severe pre-eclampsia. American Journal of Obstetrics and Gynecology 175: 1313-1316.
68. Scholtes MC, Gerretsen G & Haak HL (1983) The factor VIII ratio in normal and pathological pregnancies. European Journal of Obstetrics and Gynaecology 16: 89-95.
69. Seidman DS, Serr DM & Ben-Rafael Z (1991) Renal and ocular manifestations of hypertensive diseases of pregnancy. Obstetrical and Gynecological Survey 46: 71-76.
70. Sheehan HL & Lynch JB (eds) (1973) Pathology ofToxaemia of Pregnancy, pp 524-584. Baltimore, MD: Williams & Wilkins.
71. Shukla PK, Sharma D & Mandal RK (1978) Serum lactate dehydrogenase in detecting liver damage in pre-eclampsia. British Journal of Obstetrics and Gynaecology 85: 40-42.
72. Sibai BM (1990) The HELLP syndrome: much ado about nothing? American Journal of Obstetrics and Gynecology 162: 311-316.
73. Sibai BM, Taslimi MM, El Nazer A et al (1986) Maternal-perinatal outcome associated with the syndrome of haemolysis, elevated liver enzymes, and low platelets in severe pre-eclampsia-eclampsia. American Journal of Obstetrics and Gynecology 155: 501-509.
74. Sill PR, Lind T & Walker W (1985) Platelet values during normal pregnancy. British Journal of Obstetrics and Gynaecology 92: 480-483.
75. Simanowitz MD, MacGregor WG & Hobbs JR (1973) Proteinuria in pre-eclampsia. Journal of Obstetrics and Gynaecology of the British Commonwealth 80: 103-108.
76. Socol ML, Weiner CP, Louis G & Rossi EC (1985) Platelet activation in pre-eclampsia. American Journal of Obstetrics and Gynecology 151: 494-497.
77. Stirling Y, Woolf L, North WR et al (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis 52: 176-182.
78. Stratta P, Besso L, Canavese C et al (1996) Is pregnancy related renal failure a disappearing clinical entity? Renal Failure 18:575-584.
79. Stubbs TM, Lazarchick J, Van Dorsten JP et al (1986) Evidence of accelerated platelet production and consumption in non-thrombocytopenic pre-eclampsia. American Journal of Obstetrics and Gynecology 155: 263-265.
80. Visser W & Wallenburg HCS (1995) Temporising management of severe pre-eclampsia with and without the HELLP syndrome. British Journal of Obstetrics and Gynaecology 102: 111-117.
81. Wallenburg HCS (1988) Haemodynamics in hypertensive pregnancy. In Rubin PC (ed.) Hypertension in Pregnancy, pp 290-319. Amsterdam: Elsevier.
82. Wallmo L, Karlsson K & Teger-Nilsson AC (1984) Fibrinopeptide A and intravascular coagulation in normotensive pregnancy and parturition. Acta Obstetricia et Gynecologica Scandinavica 63: 637-640.
83. Weenink GH, Borm JJ, Ten Cate JW & Treffers PE (1983) Antithrombin III levels in normotensive and hypertensive pregnancy. Journal of the Society for Gynaecological and Obstetric Investigation 16: 230-242.
84. Weiner CP & Brandt J (1982a) Plasma antithrombin III activity: an aid in the diagnosis of pre-eclampsia-eclampsia. American Journal of Obstetrics and Gynecology 142: 275-281.
85. Weiner CP & Brandt J (1982b) Plasma antithrombin III activity in normal pregnancy. Obstetrics and Gynecology 56: 601-603.
86. *Weinstein L (1982) Syndrome of haemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 142: 159-167.